Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess whether it is feasible to establish specific cut-off values able to discriminate 'physiological' or 'pathological' brain volume rates in patients with multiple sclerosis (MS). METHODS: The study was based on the analysis of longitudinal MRI data sets of patients with MS (n=206, 87% relapsing-remitting, 7% secondary progressive and 6% primary progressive) and healthy controls (HC; n=35). Brain atrophy rates were computed over a mean follow-up of 7.5 years (range 1-12) for patients with MS and 6.3 years (range 1-12.5) for HC with the SIENA software and expressed as annualised per cent brain volume change (PBVC/y). A weighted (on the follow-up length) receiver operating characteristic analysis and the area under the curve (AUC) were used for statistics. RESULTS: The weighted PBVC/y was -0.51±0.27% in patients with MS and -0.27±0.15% in HC (p<0.0001). There was a significant age-related difference in PBVC/y between HC older and younger than 35 years of age (p=0.02), but not in patients with MS (p=0.8). The cut-off of PBVC/y, as measured by SIENA that could maximise the accuracy in discriminating patients with MS from HC, was -0.37%, with 67% sensitivity and 80% specificity. According to the observed distribution, values of PBVC/y as measured by SIENA that could define a pathological range were above -0.52% with 95% specificity, above -0.46% with 90% specificity and above -0.40% with 80% specificity. CONCLUSIONS: Our evidence-based criteria provide values able to discriminate the presence or absence of 'pathological' brain volume loss in MS with high specificity. Such results could be of great value in a clinical setting, particularly in assessing treatment efficacy in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630
Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W., & Smith, S. M. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.015 · Cited by 11,314
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis
Smith, S. M., Zhang, Y., Jenkinson, M., Chen, J., Matthews, P. M., Federico, A., & De Stefano, N. (2002) · NeuroImage · doi:10.1006/nimg.2002.1040 · Cited by 2,013
Self-citationAssociation between pathological and MRI findings in multiple sclerosis
Filippi, M., Rocca, M. A., Barkhof, F., Brück, W., Chen, J. T., Comi, G., DeLuca, G., De Stefano, N., Erickson, B. J., Evangelou, N., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70003-0 · Cited by 486
Self-citationHedman, A. M., van Haren, N. E. M., Schnack, H. G., Kahn, R. S., & Hulshoff Pol, H. E. (2012) · Human Brain Mapping · doi:10.1002/hbm.21334 · Cited by 484
The measurement and clinical relevance of brain atrophy in multiple sclerosis
Bermel, R. A., & Bakshi, R. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70349-0 · Cited by 456
Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects
Enzinger, C., Fazekas, F., Matthews, P. M., Ropele, S., Schmidt, H., Smith, S., & Schmidt, R. (2005) · Neurology · doi:10.1212/01.wnl.0000161871.83614.bb · Cited by 404
Evangelou, N. (2001) · Brain · doi:10.1093/brain/124.9.1813 · Cited by 323
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
De Stefano, N., Giorgio, A., Battaglini, M., Rovaris, M., Sormani, M. P., Barkhof, F., Korteweg, T., Enzinger, C., Fazekas, F., Calabrese, M., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e24136 · Cited by 321
Self-citationClinical Relevance of Brain Volume Measures in Multiple Sclerosis
De Stefano, N., Airas, L., Grigoriadis, N., Mattle, H. P., O’Riordan, J., Oreja-Guevara, C., Sellebjerg, F., Stankoff, B., Walczak, A., Wiendl, H., et al. (2014) · CNS Drugs · doi:10.1007/s40263-014-0140-z · Cited by 301
Self-citationSormani, M. P., Arnold, D. L., & De Stefano, N. (2014) · Annals of Neurology · doi:10.1002/ana.24018 · Cited by 297
Self-citationA randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
On behalf of the BRAVO Study Group, Vollmer, T. L., Sorensen, P. S., Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., & Arnold, D. L. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7264-4 · Cited by 194
Clinical use of brain volumetry
Giorgio, A., & De Stefano, N. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23671 · Cited by 152
Self-citationMRI evidence for multiple sclerosis as a diffuse disease of the central nervous system
Filippi, M., & Rocca, M. A. (2005) · Journal of Neurology · doi:10.1007/s00415-005-5004-5 · Cited by 145
Fully-Automated Volumetric MRI with Normative Ranges: Translation to Clinical Practice
Brewer, J. B. (2009) · Behavioural Neurology · doi:10.1155/2009/616581 · Cited by 116
Smith, S. M., Rao, A. W., Stefano, N. D., Jenkinson, M., Schott, J. M., Matthews, P. M., & Fox, N. C. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.04.035 · Cited by 110
Horáková, D., Dwyer, M. G., Havrdová, E., Cox, J. L., Doležal, O., Bergsland, N., Rimes, B., Seidl, Z., Vaněčková, M., & Zivadinov, R. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.005 · Cited by 108
Clinical impact of early brain atrophy in clinically isolated syndromes
Pérez-Miralles, F., Sastre-Garriga, J., Tintoré, M., Arrambide, G., Nos, C., Perkal, H., Río, J., Edo, M., Horga, A., Castilló, J., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513488231 · Cited by 96
A longitudinal study of brain volume changes in normal aging
Takao, H., Hayashi, N., & Ohtomo, K. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.10.011 · Cited by 93
Brain Atrophy Assessment in Multiple Sclerosis: Importance and Limitations
Giorgio, A., Battaglini, M., Smith, S. M., & Stefano, N. D. (2008) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2008.06.007 · Cited by 92
Self-citationNormal‐appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T2
Whittall, K. P., MacKay, A. L., Li, D. K. B., Vavasour, I. M., Jones, C. K., & Paty, D. W. (2002) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10076 · Cited by 92
Horáková, D., Cox, J. L., Havrdová, E., Hussein, S. M., Doležal, O., Cookfair, D. L., Dwyer, M. G., Seidl, Z., Bergsland, N., Vaněčková, M., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.120378 · Cited by 90
Paolillo, A., Caramia, F., Russo, P., Lenzi, G. L., Pozzilli, C., Piattella, M. C., Pantano, P., & Legge, S. D. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0349-8 · Cited by 71
Enhanced brain extraction improves the accuracy of brain atrophy estimation
Battaglini, M., Smith, S. M., Brogi, S., & Stefano, N. D. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.067 · Cited by 70
Self-citationFilippi, M., & Rocca, M. A. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1944 · Cited by 67
Minneboo, A., Jasperse, B., Barkhof, F., Uitdehaag, B. M. J., Knol, D. L., de Groot, V., Polman, C. H., & Castelijns, J. A. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.124123 · Cited by 65
Magnetic Resonance Approaches to Brain Aging and Alzheimer Disease-associated Neuropathology
Anderson, V. C., Litvack, Z. N., & Kaye, J. A. (2005) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245458.05654.d0 · Cited by 37
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis
van den Elskamp, I. J., Boden, B., Dattola, V., Knol, D. L., Filippi, M., Kappos, L., Fazekas, F., Wagner, K., Pohl, C., Sandbrink, R., et al. (2010) · Neuroradiology · doi:10.1007/s00234-009-0645-1 · Cited by 35
Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis
Richert, N. D., Howard, T., Frank, J. A., Stone, R. D., Ostuni, J. L., Ohayon, J. M., Bash, C. N., & McFarland, H. F. (2006) · Neurology · doi:10.1212/01.wnl.0000197982.78063.06 · Cited by 33
Determinants of Cerebral Atrophy Rate at the Time of Diagnosis of Multiple Sclerosis
Jasperse, B., Minneboo, A., de Groot, V., Kalkers, N. F., van Helden, P. E., Uitdehaag, B. M. J., Barkhof, F., & Polman, C. H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.190 · Cited by 32
Doležal, O., Gabelić, T., Horáková, D., Bergsland, N., Dwyer, M. G., Seidl, Z., Krásenský, J., Ramasamy, D. P., Vaněčková, M., Havrdová, E., et al. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.09.020 · Cited by 21
Helms, G. (2003) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-003-0006-8 · Cited by 13
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Cited by
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Brain health: time matters in multiple sclerosis
Giovannoni, G., Butzkueven, H., Dhib-Jalbut, S., Hobart, J., Kobelt, G., Pepper, G., Sormani, M. P., Thalheim, C., Traboulsee, A., & Vollmer, T. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.07.003 · Cited by 458
Self-citationDeep gray matter volume loss drives disability worsening in multiple sclerosis
Eshaghi, A., Prados, F., Brownlee, W. J., Altmann, D. R., Tur, C., Cardoso, M. J., De Angelis, F., van de Pavert, S. H., Cawley, N., De Stefano, N., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25145 · Cited by 450
Self-citationAtkins, H. L., Bowman, M., Allan, D., Anstee, G., Arnold, D. L., Bar-Or, A., Bence-Bruckler, I., Birch, P., Bredeson, C., Chen, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30169-6 · Cited by 325
Epidemiology and treatment of multiple sclerosis in elderly populations
Vaughn, C. B., Jakimovski, D., Kavak, K. S., Ramanathan, M., Benedict, R. H. B., Zivadinov, R., & Weinstock-Guttman, B. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0183-3 · Cited by 306
Metadata
- Authors
- De Stefano, N., Stromillo, M. L., Giorgio, A., Bartolozzi, M. L., Battaglini, M., Baldini, M., Portaccio, E., Amato, M. P., & Sormani, M. P.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2015-04-22
- Volume
- 87
- Issue
- 1
- Pages
- jnnp-2014-309903
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- OpenAlex
- W2123968065
- Cited by
- 256
- References
- 35
- FWCI
- 19.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.